Effectiveness of Shock Wave Therapy for Upper Limb Spasticity
1 other identifier
interventional
48
1 country
1
Brief Summary
Introduction: Shock wave therapy (SWT) has a potential interest to treat spasticity. However, the pathophysiology of this treatment remains unknown. Some authors assert that it is effective on spasticity itself, while others suggest that it acts more on fibrosis. Method: this study will assess the effectiveness of radial SWT to treat wrist and finger flexors stiffness in stroke patients, comparing subacute spastic patients (\< 12 months) with chronic patients presenting muscle contractures (\> 12 months). Forty-eight stroke patients (24 in the subacute phase and 24 in the chronic phase) will be included. One real and one sham sessions of SWT will be performed with a 2-week interval. The order of the sessions will be randomized. Motor control, stiffness and spasticity will be assessed with clinical and objective measures, just after and just before each session, by a blind assessor. The targeted muscles will be flexor carpi radialis, flexor carpi ulnaris and flexor digitorum profundus, and will be the same for the two session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Sep 2019
Longer than P75 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2019
CompletedFirst Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
March 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 13, 2023
April 1, 2023
4.2 years
January 7, 2020
April 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Modified Ashworth Scale
Clinical assessment of spasticity for wrist and fingers flexors, score from 0 to 4 (a higher score representing a greater spasticity)
Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)
Tardieu scale
Clinical assessment of spasticity for wrist and fingers flexors; score from 0 to 4 (a higher score representing a greater spasticity)
Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)
Secondary Outcomes (11)
objective measure of elastic and viscous stiffness of the wrist, expressed in N.m.rad
Before (baseline) and 5 minutes (post-treatment) after each of the two sessions (sham or real SWT)
objective measure of muscle stiffness
Before (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)
manual goniometer
Before (baseline) and 10 minutes (post-treatment) after each of the two sessions (sham or real SWT)
Medical Research Council muscle testing
Before (baseline) and 25 minutes (post-treatment) after each of the two sessions (sham or real SWT)
Isokinetic dynamometer
Before (baseline) and 15 minutes (post-treatment) after each of the two sessions (sham or real SWT)
- +6 more secondary outcomes
Study Arms (2)
interventional group
EXPERIMENTALgroup receiving shock wave therapy
control group
SHAM COMPARATORsham shock wave therapy
Interventions
Shockwave therapy is a non-invasive treatment creating a series of low energy acoustic wave pulsations that are directly applied through the skin via a gel medium
Eligibility Criteria
You may qualify if:
- History of cerebral lesion
- Wrist spasticity ≥ 1+/4 on the Modified Ashworth Scale
- Wrist spasticity ≥ 2/4 on the Tardieu Scale
- Passive dorsal extension of the wrist ≥ 10°
You may not qualify if:
- Botulinum toxin injection in the upper limb in the past three months
- History of wrist arthrodesis
- Myopathy
- Treatment with oral anticoagulants or coagulation disease
- Tumor or infection of the paretic upper limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gaëtan Stoquart, MD, PhD
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2020
First Posted
March 20, 2020
Study Start
September 2, 2019
Primary Completion
December 1, 2023
Study Completion
June 1, 2024
Last Updated
April 13, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share